Schwartz M - Search Results

1

Trial Design and Endpoints in Hepatocellular Carcinoma: AASLD Consensus Conference.

Llovet JM, Villanueva A, Marrero JA, Schwartz M, Meyer T, Galle PR, Lencioni R, Greten TF, Kudo M, Mandrekar SJ, Zhu AX, Finn RS, Roberts LR; AASLD Panel of Experts on Trial Design in HCC. Llovet JM, et al. Among authors: schwartz m. Hepatology. 2021 Jan;73 Suppl 1:158-191. doi: 10.1002/hep.31327. Epub 2020 Sep 9. Hepatology. 2021. PMID: 32430997 Review. No abstract available.

2

Macroregenerative nodules and hepatocellular carcinoma in forty-four sequential adult liver explants with cirrhosis.

Theise ND, Schwartz M, Miller C, Thung SN. Theise ND, et al. Among authors: schwartz m. Hepatology. 1992 Oct;16(4):949-55. doi: 10.1002/hep.1840160416. Hepatology. 1992. PMID: 1328012

3

Severe or multiple rejection episodes are associated with early recurrence of hepatitis C after orthotopic liver transplantation.

Sheiner PA, Schwartz ME, Mor E, Schluger LK, Theise N, Kishikawa K, Kolesnikov V, Bodenheimer H, Emre S, Miller CM. Sheiner PA, et al. Among authors: schwartz me. Hepatology. 1995 Jan;21(1):30-4. Hepatology. 1995. PMID: 7806166

4

Liver transplantation for hepatocellular carcinoma: the best treatment, but for which patient?

Schwartz ME. Schwartz ME. Hepatology. 1996 Dec;24(6):1539-41. doi: 10.1002/hep.510240640. Hepatology. 1996. PMID: 8938193 No abstract available.

5

The efficacy of prophylactic interferon alfa-2b in preventing recurrent hepatitis C after liver transplantation.

Sheiner PA, Boros P, Klion FM, Thung SN, Schluger LK, Lau JY, Mor E, Bodian C, Guy SR, Schwartz ME, Emre S, Bodenheimer HC Jr, Miller CM. Sheiner PA, et al. Among authors: schwartz me. Hepatology. 1998 Sep;28(3):831-8. doi: 10.1002/hep.510280334. Hepatology. 1998. PMID: 9731580 Clinical Trial.

6

Frequent inactivation of the tumor suppressor Kruppel-like factor 6 (KLF6) in hepatocellular carcinoma.

Kremer-Tal S, Reeves HL, Narla G, Thung SN, Schwartz M, Difeo A, Katz A, Bruix J, Bioulac-Sage P, Martignetti JA, Friedman SL. Kremer-Tal S, et al. Among authors: schwartz m. Hepatology. 2004 Nov;40(5):1047-52. doi: 10.1002/hep.20460. Hepatology. 2004. PMID: 15486921

7

Resection and liver transplantation for hepatocellular carcinoma.

Llovet JM, Schwartz M, Mazzaferro V. Llovet JM, et al. Among authors: schwartz m. Semin Liver Dis. 2005;25(2):181-200. doi: 10.1055/s-2005-871198. Semin Liver Dis. 2005. PMID: 15918147 Review.

8

How should patients with hepatocellular carcinoma recurrence after liver transplantation be treated?

Schwartz M, Roayaie S, Llovet J. Schwartz M, et al. J Hepatol. 2005 Oct;43(4):584-9. doi: 10.1016/j.jhep.2005.07.019. J Hepatol. 2005. PMID: 16120468 Review. No abstract available.

9

Expanded criteria for hepatocellular carcinoma through down-staging prior to liver transplantation: not yet there.

Llovet JM, Schwartz M, Fuster J, Bruix J. Llovet JM, et al. Among authors: schwartz m. Semin Liver Dis. 2006 Aug;26(3):248-53. doi: 10.1055/s-2006-947296. Semin Liver Dis. 2006. PMID: 16850374

10

A molecular signature to discriminate dysplastic nodules from early hepatocellular carcinoma in HCV cirrhosis.

Llovet JM, Chen Y, Wurmbach E, Roayaie S, Fiel MI, Schwartz M, Thung SN, Khitrov G, Zhang W, Villanueva A, Battiston C, Mazzaferro V, Bruix J, Waxman S, Friedman SL. Llovet JM, et al. Among authors: schwartz m. Gastroenterology. 2006 Dec;131(6):1758-67. doi: 10.1053/j.gastro.2006.09.014. Epub 2006 Sep 19. Gastroenterology. 2006. PMID: 17087938

Save citations to file

Email citations

Send citations to clipboard

Add to Collections

Add to My Bibliography

Create a file for external citation management software

Your saved search

Your RSS Feed

My Custom Filters

Publication date

Text availability

Article attribute

Article type

Article Language

Species

Sex

Age

Other

6,291 results

Search Page

Filters